多模態成像市場規模、佔有率、成長分析（按技術、按應用、按地區）- 產業預測，2024-2031 年

全球多模態成像市場規模預計從 2023 年的 41 億美元成長到 2022 年約 39 億美元，預測期內（2024-2031 年）複合年成長率為 5.6%，預計 2031 年將達到 63 億美元。預計將達到10億美元。

隨著 SPECT/CT、PET/MR 和 PET/CT 等多種成像技術的整合增強了與癌症、眼科和神經系統疾病相關的診斷能力，多模態影像市場預計將顯著成長。推動這一市場的關鍵因素包括診斷影像技術的快速進步、人口老化、醫療保健成本上升以及慢性病盛行率上升。從 2021 年到 2028 年，技術發展和現代醫療保健實踐的創新預計將為多模態成像應用創造更多商機。隨著新型顯影劑、先進檢測器和電腦輔助工具的推出，該領域正在適應不斷變化的消費者需求，並確保為患者提供準確的治療。此外，先進多模態成像技術的發展，例如利用雙功能化學染料的混合光聲螢光成像，已顯示出提高診斷準確性的潛力。隨著奈米粒子的成長，對具有可調頻譜和光穩定性的混合顯影劑的需求不斷成長，支撐了市場的收益動力。然而，多模態成像設備的高成本和醫療基礎設施不足等挑戰可能會阻礙成長。儘管存在這些障礙，美國多模態成像市場預計未來幾年將以永續的複合年成長率成長，隨著醫療保健動態的發展呈現出堅韌的前景。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價值鏈分析
• 供應鏈分析
• 專利分析
• 貿易分析
• 技術分析
• 案例研究分析
• 價格分析

多模態成像市場：依技術分類

• 市場概況
• PET/CT系統
• SPECT/CT系統
• PET/MR系統
• OCT/FMT系統
• 其他多模態成像系統

多模態成像市場：依應用分類

• 市場概況
• 腫瘤學
• 心臟病學
• 眼科
• 腦和神經病學
• 研究
• 其他用途

多模態成像市場：依最終用戶分類

• 市場概況
• 醫院
• 影像診斷中心
• 學術研究所
• 其他最終用戶

多模態成像市場規模：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• GE Healthcare
• Koninklijke Philips NV
• Canon Medical Systems Corporation
• Siemens Healthineers
• Zeiss Group
• Bruker
• Mediso Ltd.
• Neusoft Corporation
• Infraredx, Inc.（part of Nipro Corporation）
• Topcon Corporation
• Shanghai United Imaging Healthcare Co., Ltd.
• Heidelberg Engineering
• Spectrum Dynamics Medical
• Minfound Medical Systems Co., Ltd.
• Kindsway Biotech
• Sofie Biosciences, Inc.
• Fujifilm Corporation.

Global Multimodal Imaging Market size was valued at around USD 3.9 billion in 2022 and is expected to rise from USD 4.1 billion in 2023 to reach a value of USD 6.3 billion by 2031, at a CAGR of 5.6% over the forecast period (2024-2031).

The multimodal imaging market is poised for substantial growth, driven by the integration of multiple imaging technologies such as SPECT/CT, PET/MR, and PET/CT, which enhance diagnostic capabilities for conditions related to cancer, ophthalmology, and neurological disorders. Key factors propelling this market include rapid technological advancements in diagnostic imaging, an aging population, escalating healthcare costs, and the rising incidence of chronic diseases. Between 2021 and 2028, innovations in technical development and modern healthcare practices are expected to create further opportunities for multimodal imaging applications. This sector is adapting to evolving consumer needs with the introduction of new contrast agents, advanced detectors, and computer-aided tools, ensuring precise treatment delivery to patients. Additionally, the development of sophisticated multimodal imaging techniques, such as hybrid optoacoustic fluorescent imaging, which utilizes dual-function chemical dyes, showcases the potential for enhanced diagnostic precision. The increasing demand for hybrid contrast agents characterized by variable spectra and photostability, alongside the growth of nanoparticles, underscores the market's revenue momentum. However, challenges such as the high costs of multimodal imaging equipment and insufficient healthcare infrastructure may impede growth. Despite these hurdles, the U.S. multimodal imaging market is expected to grow at a sustainable compounded annual growth rate (CAGR) in the upcoming forecast years, indicating a resilient outlook amidst evolving healthcare dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Multimodal Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Multimodal Imaging Market Segmental Analysis

Global Multimodal Imaging Market is segmented by Technology, Application, End User, and region. Based on Technology, the market is segmented into PET/CT, PET/MR, SPECT/CT, OCT/FMT, and Other multimodal imaging. Based on Application, the market is segmented into Brain & Neurology, Cardiology, Oncology, Ophthalmology, Research Applications, and Other Applications. Based on End Use, the market is segmented into Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Multimodal Imaging Market

The global multimodal imaging market is poised for significant growth driven by the increasing prevalence of chronic conditions such as cancers, cardiovascular diseases, and neurological disorders. As healthcare providers recognize the need for accurate and comprehensive diagnostics, the demand for advanced multimodal imaging systems is soaring. This technology enables clinicians to integrate various imaging modalities, enhancing the identification and monitoring of chronic diseases. Furthermore, the rise in respiratory ailments, including lung cancer and COPD, is contributing to the urgent need for innovative diagnostic tools. Consequently, the escalating demand for efficient cancer screening and comprehensive disease management will propel the growth of the multimodal imaging market over the forecast period.

Restraints in the Global Multimodal Imaging Market

The Global Multimodal Imaging market faces significant restraints primarily due to the high costs associated with imaging tools and methods, which burden both patients and healthcare providers. Equipment prices, such as those for PET/CT scans ranging from $75,000 to $500,000 and gamma cameras costing between $400,000 and $600,000, pose affordability challenges, particularly in price-sensitive developing countries like India. Consequently, many healthcare facilities rely on refurbished equipment, hindering market growth. Additionally, ongoing annual maintenance costs-covering preventive upkeep, labor, and technician fees-further escalate expenses for end users. This financial strain diminishes the frequency of multimodal imaging utilization, especially in lower-income regions, ultimately stymying market expansion.

Market Trends of the Global Multimodal Imaging Market

The global multimodal imaging market is poised for significant growth, driven by ongoing technological advancements in diagnostic equipment. Innovations aimed at enhancing image quality while reducing diagnostic costs are revolutionizing patient care. Key developments include the emergence of portable imaging solutions, 5D ultrasound technology, and advancements in digital X-ray systems equipped with wireless DR detectors. The integration of three-dimensional (3D), four-dimensional (4D), and five-dimensional (5D) imaging capabilities allows for more precise diagnoses. Furthermore, companies are leveraging cutting-edge technologies such as cloud computing and artificial intelligence (AI) to refine their product offerings, positioning the multimodal imaging market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Case Study Analysis
• Pricing Analysis

Multimodal Imaging Market, By Technology

• Market Overview
• PET/CT Systems
• SPECT/CT Systems
• PET/MR Systems
• OCT/FMT Systems
• Other Multimodal Imaging Systems

Multimodal Imaging Market, By Application

• Market Overview
• Oncology
• Cardiology
• Ophthalmology
• Brain & Neurology
• Research
• Other Applications

Multimodal Imaging Market, By End User

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Academic & Research Institutes
• Other End Users

Multimodal Imaging Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeiss Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infraredx, Inc. (part of Nipro Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topcon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai United Imaging Healthcare Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heidelberg Engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Dynamics Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minfound Medical Systems Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindsway Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Corporation.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments